Nexilin antibody
Principal name
Nexilin antibody
Alternative names for Nexilin antibody
F-actin binding protein, Nelin, NEXN
Ncbi ID
NP_653174, NP_001165780.1, NM_144573, NM_199465, NM_001172309, NP_955759.2
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of Nexilin antibody
- Kit Component:
- - KN310924G1, Nexn gRNA vector 1 in pCas-Guide vector
- KN310924G2, Nexn gRNA vector 2 in pCas-Guide vector
- KN310924D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Wang,W., (2005) Biochem. Biophys. Res. Commun. 330 (4), 1127-1131
Human Liver; WB Suggested Anti-NEXN Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human Liver; NEXN antibody - middle region (ARP48028_P050) in Human Liver cells using Western Blot
Immunohistochemical staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-NEXN rabbit polyclonal antibody. (TA590405)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NEXN (RC224445, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NEXN.
ELISA: Nexilin Antibody
WB Suggested Anti-NEXN Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 312500; Positive Control: Human Liver
Lysates
| Catalog No. | ||
|---|---|---|
| LY408281 | NEXN overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR209365L2V | Lenti ORF particles, Nexn (GFP-tagged) - Mouse nexilin (Nexn), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,340.00
|
|
| OriGene Technologies, Inc. | ||
| MR209365L1V | Lenti ORF particles, Nexn (Myc-DDK-tagged) - Mouse nexilin (Nexn), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,200.00
|
|
| OriGene Technologies, Inc. | ||
